Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

ClinicalTrials.gov ID: NCT01442675

Public ClinicalTrials.gov record NCT01442675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Immunogenicity of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

Study identification

NCT ID: NCT01442675
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Enrollment: 834 participants

Conditions and interventions

Conditions

Interventions

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra® Biological

Biological

Eligibility (public fields only)

Age range: 15 Years to 55 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2011
Primary completion: May 31, 2012
Completion: Nov 30, 2012
Last update posted: Nov 17, 2014

2011 – 2012

United States locations

U.S. sites: 15
U.S. states: 11
U.S. cities: 15

Facility	City	State	ZIP	Site status
Not listed	Little Rock	Arkansas	72205	—
Not listed	San Diego	California	92103	—
Not listed	Bardstown	Kentucky	40004	—
Not listed	Crestview Hills	Kentucky	41017	—
Not listed	Spokane	Massachusetts	99202	—
Not listed	Woburn	Massachusetts	01801	—
Not listed	Niles	Michigan	49120	—
Not listed	Stevensville	Michigan	49127	—
Not listed	Rochester	New York	14618	—
Not listed	Cleveland	Ohio	44121	—
Not listed	Sellersville	Pennsylvania	18960	—
Not listed	Kingsport	Tennessee	37660	—
Not listed	Layton	Utah	84041	—
Not listed	Orem	Utah	84057	—
Not listed	Midlothian	Virginia	23113	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01442675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 17, 2014 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01442675 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →